Risk Sharing Programme
Nearly 90% of all patients become pregnant during our three treatment cycles. If the patient does not become pregnant even during the second cycle of treatment with donor oocytes, we offer the Risk Sharing Programme.
The success of treatment with donor eggs depends on the quality of formed embryos, and also on the condition of the uterine mucosa (endometrium). Compared to the available results of infertility treatment success in Europe, our clinic stands above the average and ranks among the leading European facilities.
The first and second treatment cycles are fully paid by the patient according to our current price list.
If the third cycle is necessary, the patient pays only half of the current price, and the difference to the full price is paid only if the patient becomes pregnant and foetal heart activity is confirmed by ultrasound examination.